Invitrogen™ Human SMAD4 ELISA Kit

Ref.: BL-RE-106432Manufacturer ref.: EH429RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human SMAD4 quantitates human SMAD4 in supernatant. The assay will exclusively recognize both natural and recombinant human SMAD4.

Accession number
AW743858 ; D18Wsu70e ; supprimé dans le locus du carcinome pancréatique 4 ; cible de suppression dans le carcinome pancréatique 4 ; homologue de cible de suppression dans le carcinome pancréatique 4 ; DPC4 ; hSMAD4 ; JIP ; homologue de MAD (drosophiles mères contre dcapentaplégique) 4 ; homologue de MAD 4 ; MADH4 ; homologue de mères contre décapentaplégique 4 ; mères contre décapentaplégique, drosophiles, homologue, 4 ; homologue de mères contre DPP 4 ; MYHRS ; SMAD ; SMAD 4 ; membre de la famille SMAD 4 ; SMAD, homologue de mères contre DPP 4 ; SMAD4
Dose range
1.3 to 300 ng/ml
Sensitivity of the dosage
1.3 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human SMAD4 quantitates human SMAD4 in supernatant. The assay will exclusively recognize both natural and recombinant human SMAD4.

Human SMAD4 quantitates human SMAD4 in supernatant. The assay will exclusively recognize both natural and recombinant human SMAD4.

Smad4 is encoded by the Smad4 gene on chromosome 18 in humans. Smad4 is also known as the Smad 4 family member, Sma- and Mad 4-linked protein, or D-homologist of mothers versus decapentaplegic (MAD) 4. Smad4 contains globular domains of N-terminal end MH1 (MAD 1 homology) and C-terminal end MH2 (MAD 2 homology) that are involved in DNA binding and protein interactions, respectively. The binding of the TGF-beta ligand superfamily, which includes the beta transformant growth factor (TGF-beta) and the bone morphogenetic protein (BMP) to its cognate receptor, allows the phosphorylation of Smad 1, 2, 3, 5 and 8 (R-Smad, Smad receptor). This allows the transducer of signals for heterotrimerization with Smad4 (co-Smad, Smad co-mediator) and translocation of the complex to the nucleus. The Smad inhibitor or antagonist (I-Smad) which includes Smad 6 and 7 interacts with activated R-Smads and attenuates the signaling route. Smad4 acts as a tumour suppressant protein by transcriptionally regulating its target genes such as D1 cycline (down regulation) and collagen (up regulation) that inhibit cell proliferation. Dephosphorylation regulates nuclear export and the nucleocytoplasmic dynamics of Smad.

Sensitivity

Sensitivity of the dosage: 1.3 ng/ml.

Measurement range

Dose range: 1.3 to 300 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: SMAD4.

Samples

Type of sample: Surnatant (surnatant volume, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17185209
Specifications
Accession numberAW743858; D18Wsu70e; deleted in the locus of pancreatic carcinoma 4; suppression target in pancreatic carcinoma 4; suppression target counterpart in pancreatic carcinoma 4; DPC4; hSMAD4; JIP; counterpart of MAD (mothers versus dcapentaplegic Drosophiles) 4; counterpart of
Dose range1.3 to 300 ng/ml
Sensitivity of the dosage1.3 ng/ml
ConjugateBiotin
Product typeELISA
Type of sampleSurging
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q13485
Gene symbol(s)SMAD4
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetSMAD4
Test time1 h 20 min
Physical characteristics
Volume of sampleSurnatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH429RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.